Intranasal Substituted Cathinone "Bath Salts" Psychosis Potentially Exacerbated by Diphenhydramine

被引：4
作者：
Gunderson, Erik W. [1 ,2 ,3 ]
Kirkpatrick, Matthew G. [4 ]
Willing, Laura M. [5 ]
Holstege, Christopher P. [1 ]
机构：
[1] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA
[2] Ctr Wellness & Change, Charlottesville, VA USA
[3] Columbia Univ, Coll Phys & Surg, New York, NY USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] Univ N Carolina, Sch Med, Chapel Hill, NC USA
来源：
JOURNAL OF ADDICTION MEDICINE | 2013年 / 7卷 / 03期
关键词：
bath salts; designer drug; diphenhydramine; mephedrone; 3,4-methylenedioxypyrovalerone; psychosis; LEGAL HIGHS; DRUG; HUMANS; 3,4-METHYLENEDIOXYPYROVALERONE; METHAMPHETAMINE; MEPHEDRONE; ABUSE;
D O I：
10.1097/ADM.0b013e31829084d5
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
In this report, we describe a case of intranasal "bath salts"-associated psychosis. Symptoms developed during a 3-week binge and were potentially exacerbated by oral diphenhydramine taken for insomnia. The clinical case conference includes expert discussion from 3 disciplines: emergency medicine toxicology, behavioral pharmacology, and addiction medicine. It is hoped that the discussion will provide insight into the clinical aspects and challenges of addressing acute substituted cathinone toxicity, including acute psychosis, a major adverse effect of bath salts consumption.
引用
收藏
页码：163 / 168
页数：6
相关论文
共 20 条
  • [1] Benzie Fred, 2011, Morbidity and Mortality Weekly Report, V60, P624
  • [2] Commonly prescribed medications and potential false-positive urine drug screens
    Brahm, Nancy C.
    Yeager, Lynn L.
    Fox, Mark D.
    Farmer, Kevin C.
    Palmer, Tony A.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (16) : 1344 - 1350
  • [3] Analyses of second-generation 'legal highs' in the UK: Initial findings
    Brandt, Simon D.
    Sumnall, Harry R.
    Measham, Fiona
    Cole, Jon
    [J]. DRUG TESTING AND ANALYSIS, 2010, 2 (7-8) : 377 - 382
  • [4] Drug Enforcement Agency, 2011, BACKGR DAT AN SYNTH
  • [5] "Spice" and "K2" Herbal Highs: A Case Series and Systematic Review of the Clinical Effects and Biopsychosocial Implications of Synthetic Cannabinoid Use in Humans
    Gunderson, Erik W.
    Haughey, Heather M.
    Ait-Daoud, Nassima
    Joshi, Amruta S.
    Hart, Carl L.
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2012, 21 (04) : 320 - 326
  • [6] Hatsukami Dorothy K., 1996, JAMA (Journal of the American Medical Association), V276, P1580, DOI 10.1001/jama.276.19.1580
  • [7] Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans
    Kirkpatrick, Matthew G.
    Gunderson, Erik W.
    Johanson, Chris-Ellyn
    Levin, Frances R.
    Foltin, Richard W.
    Hart, Carl L.
    [J]. ADDICTION, 2012, 107 (04) : 783 - 791
  • [8] A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans
    Kirkpatrick, Matthew G.
    Gunderson, Erik W.
    Perez, Audrey Y.
    Haney, Margaret
    Foltin, Richard W.
    Hart, Carl L.
    [J]. PSYCHOPHARMACOLOGY, 2012, 219 (01) : 109 - 122
  • [9] New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland
    Kriikku, Pirkko
    Wilhelm, Lars
    Schwarz, Olaf
    Rintatalo, Janne
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2011, 210 (1-3) : 195 - 200
  • [10] Lawrence D T, 2007, Minerva Med, V98, P543
12